High Dose Chemotherapy (HDCT) and Autologous Stem Cell Transplant (ASCT) in Childhood Cancer-Experience from the Royal Marsden Hospital

被引：0
|
作者：
Moulik, N. Roy [1 ]
Indranee, J. [1 ]
Petterson, T. [1 ]
Vaidya, S. [1 ]
机构：
[1] Royal Marsden Hosp, Paediat Oncol, Greater London, England
来源：
PEDIATRIC BLOOD & CANCER | 2017年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-117
引用
收藏
页码：S220 / S220
页数：1
相关论文
共 50 条
  • [1] High dose chemotherapy (HDCT) and autologous stem cell transplant (ASCT) in Primary Breast Lymphoma (PBL).
    Negret, LM
    Gentile, TC
    Lemke, SM
    BLOOD, 2000, 96 (11) : 373B - 373B
  • [2] High dose chemotherapy (HDCT) and autologous stem cell transplant (ASCT) in peripheral T-cell lymphoma (PTCL). A single institution experience.
    Haider, K
    Zamkoff, KW
    Gentile, TC
    BLOOD, 1999, 94 (10) : 173A - 173A
  • [3] Multicenter experience of high dose chemotherapy (HDCT) plus Autologous stem cell transplantation (ASCT) in multiple sclerosis (MS) patients.
    Shevchenko, Yury L.
    Novik, Andrei A.
    Kuznetcov, AlexeyN.
    Afanasiev, Boris V.
    Lisukov, Igor A.
    Rykavicin, Oleg A.
    Myasnikov, Alexandr A.
    Lonova, Tatiana I.
    Shamanski, Sergey V.
    Kulagin, Andrey D.
    Malysheva, Olga A.
    Baziy, Nikolay I.
    Melnichenko, Vladimir Y.
    Fedorenko, Denis A.
    Vereschagina, Inna V.
    Zdorov, Andrey E.
    Kishtovich, Anton V.
    Ivanov, Roman A.
    Fedotov, Yury N.
    Gorodokin, Gary I.
    BLOOD, 2006, 108 (11) : 875A - 875A
  • [4] Hepatic Sinusoidal Obstruction Syndrome (SOS) in Children Undergoing Autologous Stem Cell Transplant (ASCT) Following High Dose Chemotherapy (HDCT) - A Single Centre Experience from the UK
    Moulik, N. Roy
    Van Bruggen, L.
    Johnson, I.
    Petterson, T.
    Mycroft, J.
    Vaidya, S.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S23 - S24
  • [5] Experience with high dose chemotherapy (HDCT) and peripheral blood stem cell transplant (PBSCT) in a community hospital.
    Rivera, Y
    Fulman, M
    Luong, TH
    Distenfeld, A
    Mannancheril, A
    BLOOD, 1998, 92 (10) : 371B - 371B
  • [6] High dose chemotherapy with autologous stem cell transplant (ASCT) for mantle cell lymphoma (MCL).
    Segota, E
    Pohlman, B
    Jin, T
    Kuczkowski, E
    Rybicki, L
    Kalaycio, M
    Sobecks, R
    Andresen, S
    Bolwell, U
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 602S - 602S
  • [7] HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANT IN HODGKINS-DISEASE - THE ROYAL-MARSDEN-HOSPITAL EXPERIENCE
    CUNNINGHAM, D
    OBRIEN, MER
    HILL, M
    MILAN, S
    NICOLSON, M
    JONES, AL
    VINER, C
    HICKISH, T
    BLOOD, 1994, 84 (10) : A162 - A162
  • [8] Efficacy of high dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT) in metastatic breast cancer with bone only disease (BOD).
    Ponnuri, J
    Vij, R
    Adkins, D
    Brown, R
    Khoury, H
    Duerst, R
    Liesveld, J
    Abboud, C
    Dipersio, J
    BLOOD, 1999, 94 (10) : 351A - 351A
  • [9] Lack of efficacy of high-dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT) for high risk locoregional recurrence of breast cancer.
    Vij, R
    Adkins, D
    Brown, R
    Goodnough, LT
    Khoury, H
    Westervelt, P
    Biondo, M
    Freytes, C
    Bachier, C
    DiPersio, J
    BLOOD, 1998, 92 (10) : 463A - 463A
  • [10] LONG-TERM CLINICAL OUTCOME OF HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (HDCT/ASCT) FOR BREAST CANCER PATIENTS
    Jeong, S. H.
    Lee, H. W.
    Kang, S. Y.
    Park, J. S.
    Choi, J. H.
    Kim, H. C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 92 - 92
12345